glycated albumin (fructosamine) in serum
Jump to navigation
Jump to search
Introduction
Distinguish from fructosamine (isoglucosamine) in serum
Indications
- assessment of glycemic control in diabetes mellitus when hemoglobinopathy or hemolytic anemia is suspected for an incorrect hemoglobin A1c[6] (MKSAP19)
- see glycemic control
Clinical significance
- values reflect the average blood glucose for the preceding 2-3 weeks
- risk of misdiagnosing poor glycemic control ~10%, even in a selected population[5]
Methods
- Duet is an office/clinic/pharmacy based glycated albumin monitor
- In Charge Diabetes Control System is a patient monitor
- Medical insurance covers cost
More general terms
Additional terms
References
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 2023
- ↑ In Charge Diabetes Control System (888) 596-8378
http://www.inchargenow.com - ↑ Glycated Albumin Laboratory Test Directory ARUP: http://www.aruplab.com/guides/ug/tests/0080700.jsp
- ↑ Fructosamine Laboratory Test Directory ARUP: http://www.aruplab.com/guides/ug/tests/0099012.jsp
- ↑ 5.0 5.1 Narbonne H, Renacco E, Pradel V, Portugal H, Vialettes B. Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes? Diabetes Metab. 2001 Nov;27(5 Pt 1):598-603. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11694860
- ↑ 6.0 6.1 ElSayed NA, Aleppo G, Aroda VR, et al. Pharmacologic approaches to glycemic treatment: standards of care in diabetes - 2023. Diabetes Care. 2023;46:S140-S157. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36507650
Patient information
glycated albumin (fructosamine) in serum patient information